Sasaki and Plas Awarded Molecular Therapeutics Grants
Atsuo Sasaki, PhD, assistant professor of medicine, division of hematology oncology, and David Plas, PhD, associate professor of cancer biology, have each been awarded a $100,000 pilot grant award from the UC Brain Tumor Centers Molecular Therapeutics Program.
Sasakis research project is titled, "Targeting Type II PIPK for Malignant Brain Tumors. Plas research is titled, "Analysis of Apoptotic and Metabolic Effects of S6K1 Inhibitors in PTEN-Deficient Glioma.
The grants will be given over two years with funding beginning this December and second half beginning Dec. 1, 2014.
David Plas, PhD, of UC's cancer biology department
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.